
#140: How Real-World Evidence Is Shaping the Future of Multiple Sclerosis Treatment – Highlights from ECTRIMS 2025
ECTRIMS 2025 delivered powerful real-world insights into multiple sclerosis treatment. From infection risks and B-cell recovery to early high-efficacy therapy, anti-CD20 trends, and AI decision tools — the field is moving toward safer, more personalized MS care.









